CRISPR Market by Product Type (Plasmids, Vectors, CAS9 Nuclease & GRNA, Delivery System), Application (Genetic Engineering, Cell Engineering) & End User (Biotechnology & Pharmaceutical Companies, Contract Research Organization) - Global Forecast to 2023
The global CRISPR market is expected to reach USD 4.16 billion by 2023 from USD 2.01 billion in 2018, growing at a CAGR of 15.7%. Increasing incidences and prevalence of genetic disorders, rising government funding on genomic research, increasing production of genetically modified crops and increasing demand for drug discovery are some of the major factors driving the growth of the global CRISPR market.
North America dominates the CRISPR market with the North America accounted major market share in 2017. The development of gene therapy, increasing use of genetically modified (GM) crops, and rising availability of research grants and funding for genomic projects are some of the major driving factors driving the growth of this market in North America. The Asia-Pacific CRISPR market is poised to grow at the highest CAGR during the forecast period. The increasing incidences of generic disorder, rising funding on genomic research and increasing funding on genomic research are major driving factors for this market. Furthermore, emerging countries such as India and China provides immense growth opportunities to the CRISPR manufacturers.
Prominent players in the CRISPR market are Thermofisher Scientific (US), Lonza (Switzerland), Merck (Germany), Horizon Discovery Group (UK), CRISPR Therapeutics (Switzerland), Addgene (US), Editas Medicine (US) , Origene Technologies (US), Sangamo Biosciences Inc. (US) and GENSCRIPT (US)
Scope of the Report
This research report covers the global CRISPR market by method; product type; application; end user; and geography.
CRISPR Market, by Product Type
- Design Tools
- Plasmids And Vectors
- Cas9 Nuclease And GRNA
- Delivery System
CRISPR Market, BY Application
- Genetic Engineering
- Plant Genetic Engineering
- Animal Genetic Engineering
- Cell Line Engineering
- GRNA Database/Gene Library
- Others (If Any)
CRISPR Market, by End User
- Biotechnology and Pharmaceutical Companies
- Research and Academic Institutes
- Contract Research Organizations
- Others (If Any)
CRISPR Market, BY Region
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe (RoE)
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Rest of the World (RoW)
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Table of Contents
1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered in the Study
1.4 Stakeholders
2 Research Methodology
2.1 Market Size Estimation
2.2 Market Crackdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data Points Taken From Secondary Sources
2.3.2 Key Data Points Taken From Primary Sources
2.4 Assumptions
3 Executive Summary
4 Premium Insights
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.2 Restraints
5.2.3 Opportunities
5.2.4 Challenges
6 CRISPR Market, By Product Type
6.1 Introduction
6.2 Design Tools
6.3 Plasmids and Vectors
6.3 Cas9 Nuclease and Grna
6.3 Delivery System
7 CRISPR Market, By Application
7.1 Introduction
7.2 Genetic Engineering
7.2.1 Plant Genetic Engineering
7.2.2 Animal Genetic Engineering
7.3 Cell Line Engineering
7.4 Grna Database/Gene Library
7.5 Others (If Any)
8 CRISPR Market, By End User
8.1 Introduction
8.2 Biotechnology and Pharmaceutical Companies
8.3 Research and Academic Institutes
8.4 Contract Research Organizations
8.5 Others (If Any)
9 CRISPR Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe (RoE)
9.4 Asia Pacific
9.4.1 China
9.4.2 India
9.4.3 Japan
9.4.4 Rest of Asia Pacific
9.5 Rest of the World (RoW)
10 Competitive Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Competitive Situation and Trends
11 Company Profiles*
11.1 Introduction
11.2 Thermo Fisher Scientific
11.2.1 Business Overview
11.2.2 Company Snapshot
11.2.3 Products and Services
11.2.4 Recent Developments
11.2.5 MnM View
11.3 Horizon Discovery Group
11.4 Lonza
11.5 Genscript
11.6 Addgene
11.7 Merck
11.8 CRISPR Therapeutics AG
11.9 Editas Medicine
11.10 Origene Technologies
11.11 Sangamo Biosciences Inc.
Note: *Details on Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.
* 10 Market Leaders Will Be Profiled
* Segmentation May Change During the Planned Research Work
Growth opportunities and latent adjacency in CRISPR Market